How Intermittent Fasting Changes With Age

What intermittent fasting is

Intermittent fasting (IF) is an umbrella term for eating patterns that alternate between periods of voluntary fasting and periods of eating. Common synonyms include time-restricted feeding (TRF), time-restricted eating (TRE), alternate-day fasting, and Ramadan dry fasting. IF is not a drug or a single molecule; it is a behavioural schedule applied to diet. Because it has no sequence, formula, or molecular weight, the identifiers used in the literature are protocol descriptors: the length of the fasting window, whether water is permitted, and the duration of the intervention. For example, a 16:8 protocol permits eating for 8 hours and fasting for 16, with water allowed [2][6]. Ramadan dry fasting restricts both food and fluids from dawn to sunset [2].

The pathway most often discussed in this area is the cellular recycling process known as mitophagy, which clears and renews mitochondria, alongside broader metabolic and inflammatory signalling that includes insulin, GLP-1 receptor, and cytokine pathways [2][4][8].

Research Studies

Intermittent fasting and pancreatitis quality of life

A registered trial compares intermittent fasting with a standard diet approach for improving quality of life related to pancreas disease, with the stated hope of improving symptoms and preventing pancreas-related hospitalisation [1]. The study population is people with pancreatic disease; results are not yet reported in the evidence provided.

Mitophagy and mitochondrial DNA during Ramadan dry fasting versus 16:8

A registered study investigates how different fasting types affect cell health, focusing on how mitochondria are cleared and renewed. It compares Ramadan dry fasting, which restricts both food and fluids from dawn to sunset, with standard 16:8 water-permitted fasting, and examines whether the combination of fluid restriction and daily body rhythms triggers a stronger mitophagy response. Blood markers related to mitochondrial DNA and metabolic health are assessed across a 30-day period [2].

Metabolic phenotyping and personalised protocols in type 2 diabetes

A registered study tests the Snouda Metabolic Score (SMS), a tool intended to classify patients with type 2 diabetes into metabolic phenotypes spanning five systems: insulin resistance, chronic inflammation, hormonal disruption, gut microbiome imbalance, and mitochondrial dysfunction. Each participant then follows a personalised 24-week lifestyle and nutritional protocol targeting their phenotype, including dietary changes, structured exercise, and targeted nutritional supplementation [3].

Time-restricted eating and GLP-1 receptor agonists during androgen deprivation therapy

The phase II IMPACT-ADT trial compares time-restricted eating and GLP-1 receptor agonists (semaglutide and tirzepatide) with an American Heart Association heart-healthy diet in prostate cancer patients undergoing androgen deprivation therapy. The rationale is that ADT is associated with treatment-related metabolic changes, including increased weight, body fat, insulin resistance, and cardiovascular risk [4].

Probiotic intervention and weight regain in weight cyclers

A registered study evaluates a probiotic preparation in people with a history of weight cycling. The background notes that weight regain is common after caloric restriction because of metabolic adaptations, and that gut microbiota may influence appetite and metabolism [5]. This trial does not test intermittent fasting directly, but it addresses the same regain problem that fasting schedules are often used to manage.

16:8 time-restricted feeding versus calorie restriction in obese women

A 12-week study compared 16:8 time-restricted feeding plus home-based exercise with a calorie-restricted standard diet plus home-based exercise in obese women. Outcomes included body composition, lipid profile, glycemic control, and liver function enzyme levels [6].

Wearable monitoring of intermittent fasting in an N-of-1 design

A prospective N-of-1 study examines a human optimisation programme using wearable technology, correlating continuous glucose monitoring with metabolic health and overall well-being in a single individual. The background notes interest in IF for weight management, energy production, inflammation, and athletic performance during fasting periods [7].

Keto diet and intermittent fasting and oral inflammatory biomarkers

A study in an Iraqi population investigates short-term keto diet and intermittent fasting with respect to periodontal disease severity, plaque index, salivary flow and pH, and salivary inflammatory biomarkers including C-reactive protein, IL-6, TNF-alpha, and LL-37 peptide [8].

Alternate-day fasting and leptin sensitivity in the hypothalamus

Preclinical work reports that alternate-day fasting enhances leptin sensitivity through JMJD3-dependent epigenetic regulation of the leptin receptor in the hypothalamus. Leptin resistance is described as a hallmark of obesity, characterised by diminished responsiveness to leptin and disrupted energy homeostasis, with transcriptional repression of the leptin receptor impairing downstream signalling [9]. This finding is from an animal model and should not be extrapolated to human dosing or outcomes.

Intermittent fasting and the gut-endocrine axis in obese rats

An animal study reports that intermittent fasting amplifies gut-endocrine axis responses to Senna alexandrina supplementation in obese rats. The model uses a high-fat, high-sucrose diet to induce obesity, which disrupts lipid metabolism, glucose homeostasis, and gut microbial balance [10]. This is animal-only evidence.

Comparison of selected fasting protocols in the evidence

If you are reading this for personal health reasons

The materials and protocols described here are discussed in the context of laboratory and clinical research, and we do not sell them for personal use or provide dosing or medical guidance. Nothing on this page is a recommendation for any individual. Anyone considering a fasting regimen or any related compound for themselves should speak to a licensed clinician.

Sources

• [1] Intermittent Fasting for Pancreatitis — https://clinicaltrials.gov/study/NCT04760847
• [2] Mitophagy and Mitochondrial DNA Dynamics During Ramadan Dry Fasting vs 16:8 Time-Restricted Feeding — https://clinicaltrials.gov/study/NCT07638696
• [3] Validation of the Snouda Metabolic Score for Phenotyping and Guiding Reversal in Type 2 Diabetes — https://clinicaltrials.gov/study/NCT07606872
• [4] Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial — https://clinicaltrials.gov/study/NCT07202247
• [5] Study on the Weight Loss Effects and Mechanisms of Probiotic Preparation Intervention in Weight Cyclers — https://clinicaltrials.gov/study/NCT07031596
• [6] Comparison of the Effects of Intermittent Fasting and Frequent Feeding Strategies on Weight Loss in Obese Women — https://clinicaltrials.gov/study/NCT07826065
• [7] Monitoring Intermittent Fasting for Human Optimization Using Wearable Technology: An N-of-1 Study — https://clinicaltrials.gov/study/NCT06630637
• [8] Dietary Diversities: Exploring the Influence of Keto Diet and Intermittent Fasting on Oral Health and Salivary Inflammatory Biomarkers — https://clinicaltrials.gov/study/NCT06597708
• [9] Alternate-day fasting enhances leptin sensitivity via JMJD3-dependent epigenetic regulation of the leptin receptor in the hypothalamus — https://europepmc.org/article/PMC/PMC13480440
• [10] Intermittent Fasting Amplifies Gut-Endocrine Axis Responses to Senna alexandrina Supplementation in Obese Rats — https://pubmed.ncbi.nlm.nih.gov/42504494/